In the CHO/HER2, BT-474, and SK-BR-3 xenograft tumor-bearing BALB/c nude mice, humH2Mab-250, trastuzumab, or control human IgG1 was intraperitoneally administered on days 7, 14, and 21. The gene discussed is ERBB2; the disease is neoplasm.